2,257 material Form 8-K filings that 1,923 companies we cover made with the SEC in November 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). 1,081 of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Lake Superior Acquisition Corp. signed an Amended and Restated Business Combination Agreement on November 3, 2026, with Openmarkets Group and related parties, restructuring the pre-closing ownership of Pubco and the order of the transactions. The closing exchange consideration of $300 million is unchanged, as are the milestone consideration terms, and the outside date is extended to March 31, 2027, which gives shareholders a longer window for the deal to close.
Closing exchange consideration of $300,000,000, payable in Pubco ordinary shares at a deemed value of $10.00 per share
Milestone consideration of up to $300,000,000 (license) and up to $400,000,000 (performance), held in escrow as Pubco shares totaling $700,000,000
Outside date extended from December 31, 2026 to March 31, 2027
Lake Superior is to be liquidated after closing, with its assets transferred to Pubco
Bio-Techne's board declared a $0.08 per share cash dividend for the quarter ended September 30, 2026. The payment is conditional on the pending transaction with Merck KGaA, Darmstadt, Germany not closing on or before the November 13, 2026 record date, so the dividend tie-in to that deal matters to shareholders.
Dividend of $0.08 per share for the quarter ended September 30, 2026
Payable November 23, 2026 to common shareholders of record at close of business November 13, 2026
Dividend applies only if the Merck KGaA transaction has not closed on or before November 13, 2026
Future dividends will be considered by the Board on a quarterly basis
Z Squared Inc. elected Jeffery Harris, its Chief Technology Officer, as a director effective November 3, 2026, filling the seat left vacant by Michelle Burke's May 22, 2026 resignation. Harris is an employee and executive officer, so he is not independent, but three of the five directors remain independent, keeping a majority under Nasdaq rules. He receives no additional director compensation.
Jeffery Harris, age 40, elected director effective November 3, 2026, filling the vacancy left by Michelle Burke's resignation
Board remains at five directors; three (Adam Sohn, Bryan Fuerst, Kenneth Cooper) are independent
Harris is not named to any board committee and receives no additional director compensation
Filing notes ongoing commercial relationships with Paradox Infrastructure LLC and Paradox Energy LLC, in which Harris holds membership interests
Wabtec priced a $500 million offering of 5.900% Senior Notes due 2037 on November 2, 2026. The company plans to use the proceeds, together with borrowings under its revolving credit facilities, short-term facilities and/or commercial paper, to repay its 3.450% Senior Notes due November 15, 2026. The sale is expected to close on November 4, 2026.
Offering: $500 million aggregate principal of 5.900% Senior Notes due February 25, 2037, priced November 2, 2026
Use of proceeds: repay the 3.450% Senior Notes due 2026 at maturity on November 15, 2026, alongside other borrowings
Expected closing: November 4, 2026, subject to customary closing conditions
Joint book-running managers: BofA Securities, Citigroup Global Markets, PNC Capital Markets and TD Securities
CHS Inc. declared regular quarterly dividends on five series of its preferred stock on November 3, 2026. The payments are $0.50, $0.492188, $0.443750, $0.421875 and $0.468750 per share, each on a $25.00 per share preferred, payable December 31, 2026 to holders of record on December 16, 2026. The filing is a routine dividend notice and does not change results or the company's outlook.
Five preferred series declared: 8% Cumulative Redeemable, Class B Series 1, Series 2 and Series 3 (Reset Rate), and Series 4
Per-share dividends of $0.50, $0.492188, $0.443750, $0.421875 and $0.468750 on $25.00 per share preferred
Payable December 31, 2026 to shareholders of record on December 16, 2026
Avantor's compensation committee approved a special long-term incentive award for Executive Vice President and Chief Legal and Compliance Officer Claudius Sokenu, recognizing his work in litigation, regulatory management, dispute resolution and corporate governance. The award is 62,305 restricted stock units granted October 31, 2026, under the company's 2019 Equity Incentive Plan. The filing describes a routine compensation grant that does not change executive leadership and gives no financial results.
Award: 62,305 restricted stock units granted October 31, 2026, to Claudius Sokenu
Vesting: equal installments on the first three anniversaries of the grant date, subject to continued employment
Approved by the Compensation and Human Resources Committee on October 30, 2026
Enovix disclosed that Arthi Chakravarthy, its Chief Legal Officer and Corporate Secretary, has departed the company, effective October 30, 2026. The filing does not give a reason for the departure or name a successor.
Arthi Chakravarthy, Chief Legal Officer and Corporate Secretary, departed effective October 30, 2026
Filing dated November 3, 2026, signed by Ryan Benton, Interim Chief Executive Officer
No successor or replacement arrangement is named in the filing
Concentrix Corporation announced that Chinnu Susan Varghese will succeed Andre Valentine as Chief Financial Officer effective December 1, 2026. Mr. Valentine will remain in the role in the near term and stay through the second quarter of fiscal 2027 to support the transition.
Chinnu Susan Varghese joins Concentrix on November 9, 2026 and becomes CFO on December 1, 2026.
Andre Valentine stays on as CFO in the near term and is expected to remain with the company through the second quarter of fiscal 2027.
Ms. Varghese previously was Senior Vice President and Group Controller at Marelli and CFO, Global Growth Markets at Cognizant.
Titan Acquisition Corp. furnished an investor presentation under Regulation FD for its proposed business combination with OpenPayd Holdings Limited, for use in meetings with existing and potential shareholders. The presentation reports first-half revenue of $47.5 million, up 43% year over year, but the filing does not report new audited results or final deal terms, and the company states that the transaction may not be consummated as described.
Exhibit 99.1 is an investor presentation dated November 2026, furnished under Item 7.01 and tied to the business combination described in an 8-K filed June 1, 2026, as amended July 9, 2026.
The presentation cites H1 revenue of $47.5 million, up 43% year over year, and more than 1,260 clients.
Figures as of October 31, 2026 include $360 billion+ annualized transaction volume and $107 million of Annual Recurring Revenue, which the company says is not an IFRS measure.
The presentation says a Nasdaq listing is anticipated by calendar Q4 2026, and that terms are under negotiation and subject to change.
Avidia Bancorp, Inc. completed its previously reported plan to repurchase up to $30 million in value of its common stock on November 3, 2026. The company bought 1,355,565 shares at a weighted average price of $22.10 per share, excluding commissions and excise taxes, which reduces the number of shares outstanding for existing shareholders.
Buyback plan of up to $30 million in value completed on November 3, 2026
1,355,565 shares repurchased at a weighted average price of $22.10 per share
Price excludes commissions and excise taxes; filing made under Item 8.01 (Other Events)
AH Realty Trust's operating partnership entered new credit agreements on October 28, 2026, providing a $150.0 million revolving credit facility and three term loans totaling $500.0 million, which replace four prior loan facilities. The filing also describes a separate $121.8 million secured term loan for subsidiaries that own the Constellation Tower property, with the financing terms and covenants taking effect for shareholders as a refinancing of existing debt.
On October 28, 2026, the operating partnership signed a Fourth Amended and Restated Credit Agreement with Bank of America, N.A. as administrative agent, including a $150.0 million revolver maturing October 28, 2031, a $200.0 million 4-year
A separate $100.0 million 7-year term loan maturing October 28, 2033 was arranged with Toronto Dominion (Texas) LLC, with an accordion feature allowing increases up to $250.0 million maximum outstanding.
The new loans replace a $355.0 million revolver, a $350.0 million term loan, a $135.0 million term loan with Manufacturers and Traders Trust Company, and a $95.0 million term loan with Toronto Dominion (Texas) LLC.
Constellation subsidiaries entered a $121.8 million term loan maturing October 28, 2029 with PNC Bank, N.A., priced at Daily Simple SOFR plus 1.80% and secured by the Constellation Tower property.
At its October 29, 2026 annual meeting, Autonomix Medical stockholders approved an increase of 750,000 shares under the 2023 Stock Plan and authorized the board to seek a reverse stock split of between 1-for-2 and 1-for-25. All six director nominees were elected, and Forvis Mazars, LLP was ratified as the independent auditor for the year ending March 31, 2027. The votes give the board flexibility on share count and equity awards, but the filing does not say whether a reverse split will be pursued.
Annual meeting held October 29, 2026; 905,610 shares voted, about 46% of 1,959,938 shares outstanding as of the September 8, 2026 record date.
2023 Stock Plan amended to add 750,000 shares; total issuable under the plan is 750,353 shares.
Reverse split proposal approved with 775,257 votes for and 110,036 against, authority valid until the one-year anniversary of the meeting.
Plan amendment approved with 225,651 votes for and 39,672 against.
NeOnc Technologies Holdings announced that data from its intranasal NEO100 and oral NEO212 programs will be presented in two posters on November 13, 2026, at the 31st Annual Meeting of the Society for Neuro-Oncology in Philadelphia. The filing is an announcement of scheduled presentations and contains no financial results, guidance, or new financing terms.
Two poster presentations scheduled for Friday, November 13, 2026, 7:30 to 9:30 p.m. EST, at the Pennsylvania Convention Center in Philadelphia
NEO100 poster: updated Phase 1/2a results in recurrent WHO Grade III/IV IDH1-Mutant Astrocytoma, presented by Thomas C. Chen, MD, PhD
NEO212 poster: Phase 1 safety, pharmacokinetics and early activity signals in TMZ-Resistant recurrent GBM, presented by Josh Neman, PhD
Both NEO100 and NEO212 remain investigational and have not been approved by any regulatory authority
On October 28, 2026, Optimum Communications increased its board from nine to eleven directors and appointed Elizabeth Abrams and Daniel Silvers, both determined to be independent. The board also created a special committee of these two directors with authority to evaluate potential financing, restructuring, or recapitalization transactions and conflict-of-interest matters involving related parties.
Board size increased from nine to eleven directors effective October 28, 2026.
Each new director will receive a monthly fee of $75,000 under an Independent Director Agreement.
Silvers' brother is a partner at Ropes & Gray LLP, which the company paid approximately $11 million for legal services since January 1, 2025.
Special Committee members are Abrams and Silvers, with delegated power to review potential strategic and financial transactions.
Acadia Realty Trust filed a new automatic shelf registration on Form S-3 to replace its 2023 shelf, which expires November 7, 2026, and amended its at-the-market equity offering program. The amendment adds Citizens JMP Securities as an additional sales agent and forward purchaser, and about $199 million remains available under the program. The filing describes routine capital-raising housekeeping, and it signals that the company can issue new common shares under the program, which would dilute existing holders if used.
New automatic shelf registration on Form S-3 filed November 3, 2026, replacing the 2023 shelf that expires November 7, 2026
Amendment No. 1 covers common shares with an aggregate sale price of up to $500 million under the at-the-market program
As of the amendment date, up to $199,062,233.91 in common shares remained available for issuance under the program
Citizens JMP Securities, LLC added as an additional sales agent and forward purchaser
On November 3, 2026, the Board of Directors of National Bank Holdings Corporation declared a cash dividend of $0.33 per share on its Class A common stock. The press release describes the payment as an increase to the quarterly dividend, but the filing does not state the prior amount. Future dividends remain subject to Board approval and will depend on the company's financial position, results and capital requirements.
Cash dividend of $0.33 per share on Class A common stock, declared November 3, 2026
Record date is November 27, 2026 (close of business); payment date is December 15, 2026
Press release, filed as Exhibit 99.1, calls it an increase to the quarterly dividend; prior dividend amount not stated
Future dividends are at the Board's discretion and depend on financial position, results, cash flows and capital requirements
ProShares Trust II announced a 1-for-2 reverse split of the ProShares VIX Mid-Term Futures ETF (VIXM), effective before market open on November 19, 2026. The company says the split will not change the value of a shareholder's investment, but fractional shares created by the split will be redeemed for cash, which may be a taxable event.
VIXM ticker stays the same; the fund receives new CUSIP 74347Y649 and each two pre-split shares become one post-split share.
Fractional post-split shares will be redeemed for cash and sent to the shareholder's broker of record.
The same press release covers 15 ETFs in total: three forward splits (EET and ROM at 3:1, BIB at 2:1) and 12 reverse splits, including VIXM.
Capital City Bank Group furnished a third quarter 2026 investor presentation under Regulation FD, posting it to its website and filing it as Exhibit 99.1 to a Form 8-K dated November 3, 2026. The filing itself contains no financial results, guidance, or other figures, so its direct effect on shareholders is limited to the presentation's content, which the filing does not describe.
Investor presentation for third quarter 2026 posted to www.ccbg.com
Presentation furnished as Exhibit 99.1 and not deemed filed under Section 18 of the Exchange Act
Filing signed November 3, 2026 by Jeptha E. Larkin, Executive Vice President and Chief Financial Officer
On November 3, 2026, Procter & Gamble closed an underwritten public offering of four series of euro-denominated notes under its existing Form S-3 shelf registration, totaling €3.25 billion in principal. The notes mature between 2030 and 2046 and carry coupons from 3.750% to 4.625%, so the offering adds long-term debt to the company's balance sheet.
Four tranches: €750 million due November 3, 2030 at 3.750%; €1.0 billion due November 3, 2034 at 4.100%; €750 million due November 3, 2038 at 4.250%; €750 million due November 3, 2046 at 4.625%
Offering closed on November 3, 2026, under Registration No. 333-299472
Legal opinions filed as Exhibits 5(a) and 5(b); the filing does not state the use of proceeds
IFF's board approved one-time equity and cash incentive awards for executives, including the CEO and CFO, tied to closing the previously announced sale of its Food Ingredients business. The board also adopted amended bylaws that allow stockholder meetings to be held solely by remote communication.
Named executive awards total $700,000 for CEO J. Erik Fyrwald (RSUs with three-year cliff vesting), CFO Michael DeVeau, and President Leticia Gonçalves Lourenço, plus $350,000 for Yuvraj Arora
No award vests or is paid unless the Food Ingredients sale closes; awards are forfeited if the agreement is terminated
Amended and restated bylaws took effect October 28, 2026 and permit remote-only stockholder meetings
Accendra Health's Executive Vice President and Chief Operating Officer, Perry Bernocchi, will cease to be an executive officer under a transition agreement dated October 29, 2026, and serve as Strategic Advisor to the CEO until December 31, 2026, unless his employment ends earlier. He keeps his current base salary and remains eligible for his 2026 annual bonus at target and for applicable severance, which matters to shareholders as a senior operating leadership change.
Perry A. Bernocchi, EVP and Chief Operating Officer, ceases to be an executive officer under agreement dated October 29, 2026
Serves as Strategic Advisor to the Chief Executive Officer until December 31, 2026, unless employment ends earlier
Keeps current base salary and remains eligible for 2026 annual bonus at current target
Remains eligible for severance under Officer Severance Policy or change of control agreement, as applicable
Ring Energy disclosed that director Richard Harris is retiring from its board of directors, effective October 28, 2026. The filing states his decision was not the result of any dispute or disagreement with the company on its operations, policies, or practices.
Richard Harris notified the board on October 28, 2026 of his retirement.
Retirement is effective October 28, 2026.
Filing states no dispute or disagreement with the company led to the decision.
8-K signed by CFO Sundip S. Johl on November 3, 2026.
Guardant Health increased its board to 11 seats and appointed Kevin R. Sayer, former Dexcom CEO, as a Class II director effective November 2, 2026. The company also named Robert A. Parks as Chief Accounting Officer and principal accounting officer on the same date, replacing no named predecessor in the filing. The changes add board and finance leadership but the filing discloses no financial results.
Kevin R. Sayer, 68, appointed Class II director effective November 2, 2026, with a term expiring at the 2029 Annual Meeting
Sayer to receive a restricted stock unit award valued at $500,000 and a $60,000 annual cash retainer
Robert A. Parks, 54, appointed Chief Accounting Officer and principal accounting officer; previously CAO of Fortrea Holdings Inc. from August 2024 to August 2026
Enova International furnished a Form 8-K disclosing a proposed private offering of $500,251,000 in Series 2026-2 fixed rate asset-backed notes by subsidiary OnDeck Asset Securitization IV, LLC, backed by small business loans from OnDeck. The filing also furnishes supplemental historical loan performance data made available to potential note purchasers, and the notes will not be obligations of or guaranteed by Enova or OnDeck, so shareholders' direct exposure is limited to the terms and completion of the offering.
Proposed offering of $500,251,000 aggregate principal amount of Series 2026-2 Fixed Rate Asset-Backed Notes by OnDeck Asset Securitization IV, LLC
Issuer is sole obligor; notes are not obligations of, or guaranteed by, Enova or OnDeck
Notes offered only to qualified institutional buyers under Rule 144A and non-U.S. persons under Regulation S; terms and timing depend on market conditions
Supplemental data was made available to potential purchasers on November 3, 2026, covering term loans and lines of credit with original terms of 24 months or less and minimum loan yields of at least 10%
Wolverine World Wide disclosed a separation agreement with Susie Kuhn, who stopped serving as President, Active Group on September 21, 2026. The agreement, effective October 31, 2026, provides severance, benefits, a prorated fiscal 2026 bonus payable if at all, and restrictive covenants on her. The filing does not state any financial impact on the company's results.
Kuhn ceased serving as President, Active Group on September 21, 2026, as previously disclosed.
Severance equals one year of base salary, paid bi-weekly, plus health care continuation benefits.
Prorated fiscal 2026 bonus is payable based on actual company performance, if at all, after active employees are paid.
Non-compete runs through October 31, 2027; non-solicitation runs through September 21, 2027.
Solstice Advanced Materials said its Board declared a regular quarterly cash dividend of $0.075 per share on common stock. Shareowners of record at the close of business on November 25, 2026 will receive the payment on December 10, 2026. The filing reports a routine dividend declaration and does not include financial results or guidance.
Quarterly dividend of $0.075 per common share, announced November 3, 2026
Record date is November 25, 2026; payment date is December 10, 2026
Dividend declared by the Board of Directors; terms are described in Exhibit 99.1 press release
ACM Research, Inc. announced that Yue Ma began work as Chief Operations Officer effective October 1, 2026, under an offer letter with a $375,000 base salary and a $100,000 target annual bonus. The filing also discloses equity grants and a sign-on bonus, which give the company a clear view of the cost of the appointment.
Base salary of $375,000 and target annual bonus of $100,000
Stock option for 100,000 Class A shares at $83.58 per share, vesting from October 1, 2027
Restricted stock units for 13,470 shares, vesting in four annual installments; one-time $50,000 sign-on bonus and relocation benefits up to $150,000
U.S. GoldMining appointed John DeLucchi to its Board of Directors on November 2, 2026, filling a vacancy and making him Chair of the Audit Committee. The company says this restores compliance with Nasdaq's audit committee requirements, which it had lost after a director's resignation, as previously reported by Nasdaq notice on August 27, 2026.
Board appointment effective November 2, 2026, filling the vacancy left by Aleksandra Bukacheva's resignation
Nasdaq notice dated August 27, 2026 cited non-compliance with Listing Rule 5605; company says compliance is now regained
DeLucchi receives a US$10,000 annual director retainer plus US$2,500 for Audit Committee chair, and an option on 10,000 shares at $5.71
First Community Corporation furnished an investor presentation as Exhibit 99.1 to this Form 8-K, for use by management in meetings with investors on November 4-6, 2026, at the 2026 Hovde Group Financial Services Conference in Orlando, Florida. The presentation covers third-quarter 2026 highlights, including a leadership transition, the Signature Bank of Georgia acquisition, and an appendix with the second-quarter 2026 earnings release. The exhibit is furnished to, not filed with, the SEC.
Presentation to be used in investor meetings November 4-6, 2026, at the Hovde Group conference in Orlando, Florida.
Presentation reports $2.4 billion in total assets at September 30, 2026, and a cash dividend of $0.17 per share payable November 17, 2026.
Leadership transition: Ted Nissen retires December 31, 2026; Vaughan Dozier becomes bank CEO and Drew Painter bank president effective January 1, 2027.
Exhibit 99.1 is furnished to, not filed with, the SEC.
On November 3, 2026, H2O America issued and sold 7,475,000 corporate units under an October 29, 2026 underwriting agreement with Wells Fargo Securities and J.P. Morgan Securities as representatives. Each unit combines a stock purchase contract requiring the holder to buy common stock by November 1, 2029 with a 1/20 interest in $1,000 of 5.300% remarketable senior notes due 2031, so the sale may lead to new common shares being issued.
7,475,000 corporate units sold, including 975,000 units from the full exercise of the underwriters' over-allotment option.
Each unit has a $50 stated amount; the stock purchase contract is due no later than November 1, 2029, for $50 in cash per contract.
Total annual distributions are 7.750% of the stated amount: 2.450% in contract adjustment payments and 5.300% in note interest.
The senior notes will be remarketed before the stock purchase contract settlement date, under a remarketing agreement not yet signed as of the filing.
Blue Acquisition Corp, a Cayman Islands blank-check company, issued an unsecured, non-interest-bearing promissory note of up to $50,000 to director Dario Dino Ferrari to fund working capital. The note is repayable only upon completion of its proposed business combination with Blockfusion USA, Inc. or on liquidation, and repayment outside the trust account is limited to any funds remaining there, which is a modest financing step with limited dilution-free funding for shareholders.
Unsecured promissory note issued November 3, 2026, for up to $50,000 to director Dario Dino Ferrari
Note bears no interest; principal due on the earlier of the Blockfusion business combination or liquidation
Payee waives claims against the trust account; repayment otherwise limited to funds outside the trust, if any
NBT Bancorp made available an investor presentation that its executive management team intends to use at future meetings with investors and analysts. The filing is a Regulation FD disclosure with no financial results, guidance, or transaction details.
Filed November 3, 2026 under Item 7.01 (Regulation FD Disclosure)
Presentation slides are posted on the Investor Presentations page of the company's website at www.nbtbancorp.com
Filing is signed by Annette L. Burns, Executive Vice President and Chief Financial Officer
Matinas BioPharma Holdings and a former financial advisor terminated their agreement on November 3, 2026. The agreement had provided for up to $2.0 million in cash and up to $2.0 million in stock tied to certain business combinations, and the company paid the advisor $562,500 in cash as part of the termination.
Agreement terminated November 3, 2026 between Matinas and a former financial advisor
Agreement had provided for up to $2.0 million in cash and up to $2.0 million in stock tied to certain business combinations
Company paid the advisor $562,500 in cash; the parties exchanged mutual releases, subject to certain contingencies
Sands China, a majority-owned subsidiary of Las Vegas Sands, completed a $1.0 billion private offering of senior unsecured notes on November 3, 2026. The company said it intends to use the proceeds and cash on hand to redeem its $700 million 2.300% notes due 2027, repay its 2024 SCL Revolving Facility balance, and for general corporate purposes. The filing does not state a direct effect on Las Vegas Sands' reported results, but the new debt is an obligation of its Hong Kong-listed subsidiary.
$700 million of 6.400% Senior Notes due 2032 and $300 million of 6.700% Senior Notes due 2033, totaling $1.0 billion
Notes mature January 8, 2032 and November 8, 2033; both are listed on The Stock Exchange of Hong Kong
Proceeds, with cash on hand, intended to redeem in full the $700 million 2.300% notes due 2027 and repay the 2024 SCL Revolving Facility balance
Notes are unguaranteed by Sands China's subsidiaries and structurally subordinated to their liabilities
At its October 29, 2026 annual meeting, QuinStreet shareholders re-elected three Class II directors to terms ending at the 2029 annual meeting, ratified PricewaterhouseCoopers LLP as auditor for fiscal 2027, approved a non-binding advisory vote on executive pay, and approved an increase of 2,164,999 shares to the 2021 Employee Stock Purchase Plan. The filing reports shareholder votes and an added plan exhibit, with no financial results or changes in officers reported.
Annual meeting held October 29, 2026; 92.75% of 57,223,392 outstanding shares were present or represented by proxy
ESPP reserve increased by 2,164,999 shares; approved by 43,431,639 votes for and 354,235 against
Auditor PricewaterhouseCoopers LLP ratified for fiscal year ending June 30, 2027 with 51,835,662 votes for
Bridgewater Bancshares furnished an investor presentation dated November 3, 2026, for use in meetings with investors and analysts, filed under Item 7.01 as Exhibit 99.1. The presentation reports third-quarter 2026 loan and deposit growth and balance sheet figures as of September 30, 2026, and the filing states the material is not deemed filed under the Exchange Act.
Investor presentation dated November 3, 2026, furnished as Exhibit 99.1 under Item 7.01
SiriusPoint Ltd. announced that John Sauerland, a former Progressive Insurance Chief Financial Officer with more than 35 years of insurance industry experience, will join its Board of Directors effective January 1, 2027. The Board has determined he is independent and an audit committee financial expert, and he will receive the same director compensation as the company's other non-employee directors.
Appointment effective January 1, 2027, as a Class I director with a term running until the 2029 annual general meeting of shareholders
Previously served as Chief Financial Officer at Progressive Insurance and has more than 35 years of insurance industry experience
Board determined he is independent under NYSE and Exchange Act requirements and qualifies as an audit committee financial expert
No committee appointments yet; the company will file an amendment to this Form 8-K when they are determined
Pfizer's board unanimously elected Cecile Guegan as Chief Financial Officer and Executive Vice President, effective November 1, 2026, after she served as interim CFO since August 16, 2026. The filing sets her base salary at $1,300,000 and her target annual cash incentive at $1,300,000, and it does not report any financial results or change to guidance.
Cecile Guegan appointed CFO and Executive Vice President, effective November 1, 2026; interim CFO since August 16, 2026
Annual base salary of $1,300,000
Annual target cash incentive of $1,300,000, equal to 100% of base salary
She will oversee all corporate finance functions, including audit, treasury, investor relations and tax
On October 30, 2026, MacroGenics increased its Board from ten to eleven members and appointed Michael Vasconcelles and Emil Kuriakose as independent directors, effective that day. Both were also placed on the Science and Technology Committee and will receive director compensation, including initial option and restricted stock unit awards, which adds modest equity dilution for shareholders. The filing reports no financial results.
Board size increased from ten to eleven members, approved October 30, 2026.
Michael Vasconcelles named Class II Director and Emil Kuriakose named Class III Director, effective October 30, 2026.
Each director receives an option for 44,000 shares and a restricted stock unit grant for 7,500 shares under the 2023 Equity Incentive Plan.
Both directors were determined to be independent and joined the Science and Technology Committee.
TXO Partners, L.P. said its general partner declared a third-quarter 2026 distribution of $0.44 per common unit for the quarter ended September 30, 2026. Unitholders of record at the close of trading on November 13, 2026, will receive the payment on November 20, 2026, and the filing includes no new earnings or revenue figures. The company also posted an investor presentation on its website, which it furnished as an exhibit.
Distribution of $0.44 per common unit for the quarter ended September 30, 2026
Record date November 13, 2026; payment date November 20, 2026
Quarterly Report on Form 10-Q for the same quarter to be filed on November 3, 2026
Investor presentation dated November 2026 posted to the company website
Radian Group's UK subsidiary ICML amended and restated its letter of credit facility with a syndicate of banks led by Barclays, raising lender commitments from $620 million to $880 million. Radian Group is now guarantor of ICML's obligations, replacing Inigo Limited, and the facility supports ICML's Lloyd's underwriting for the 2027 year of account and prior open years. The facility carries financial covenants and cross-default risk to Radian Group's revolving credit facility and senior notes.
Lender commitments increased from $620 million to $880 million, effective October 29, 2026
Radian Group added as guarantor; Inigo Limited removed as guarantor
Letters of credit have a minimum term of four years and expire no later than December 31, 2030
Covenants include minimum consolidated net worth and maximum Debt-to-Total Capitalization; a default could trigger defaults under Radian Group's RCF and senior notes
Liminatus Pharma agreed on November 2, 2026 to sell 260,001 common shares at $2.50 each in a private placement to a non-U.S. investor, raising gross proceeds of $650,002.50. The company plans to use the proceeds for working capital and general corporate purposes, with closing expected on or about November 20, 2026. The company also agreed to file a resale registration statement within 60 days of closing, which could add shares that may be sold into the market later.
Shares: 260,001 common shares at $2.50 per share
Gross proceeds: $650,002.50, for working capital and general corporate purposes
Expected closing: on or about November 20, 2026
Company must file a resale registration statement with the SEC within 60 days of closing
American Strategic Investment Co. (NYSE: NYC) said it will release its third quarter 2026 financial results on Friday, November 13, 2026, before the New York Stock Exchange opens. The company will not host a webcast or conference call, and the filing contains no financial results. For shareholders, this is a scheduling notice, but the forward-looking statements reference the company's ability to return to compliance with NYSE continued listing standards.
Third quarter 2026 results (quarter ended September 30, 2026) will be released on November 13, 2026, before the NYSE open.
No webcast or conference call will be held.
Forward-looking statements cite the company's ability to return to compliance with NYSE continued listing standards.
The filing also cites the anticipated benefits of the company's election to terminate its REIT status.
Willis Towers Watson said Steven Alcock, 47, will succeed Joseph Kurpis as Principal Accounting Officer and Controller, effective April 1, 2027, as Kurpis retires. Alcock has been Head of Finance, International since January 2022 and has been CFO of Willis Limited, a U.K. subsidiary, since December 2025. The change is a routine succession in a finance role and does not include any disclosed change to financial results or guidance.
Steven Alcock, 47, appointed to succeed Joseph Kurpis as Principal Accounting Officer and Controller
Effective date: April 1, 2027
Alcock joined the company in 1997 and has been Head of Finance, International since January 2022
Filing states no arrangements with other persons and no family relationships with directors or executive officers
BNB Standard Corporation increased its board from six to seven directors and appointed Anthony Scaramucci, founder and Managing Partner of SkyBridge Capital, effective November 3, 2026. The appointment fulfills a provision of the company's June 23, 2026 cooperation agreement with YZiLabs, under which the parties agreed to add a new independent director. The filing reports no financial results or changes to company operations.
Board size increased from six to seven directors; Scaramucci fills the new seat effective November 3, 2026.
Appointed under Section 1(c) of the Cooperation Agreement dated June 23, 2026 with YZiLabs Management Ltd.
Board has not assigned Scaramucci to any committee; the company states he is independent under Nasdaq standards.
Scaramucci is scheduled to host a fireside chat with CEO Alex Odagiu at the SALT Conference in London on November 4, 2026.
On November 3, 2026, First American Financial Corporation appointed Darryl D. Button to its Board of Directors, and he has not yet been named to any board committee. Button has been president and CEO of Pacific Mutual Holding Company since April 2022 and previously served as First American's chief financial officer from 2017 to 2021, so the appointment adds a director with prior company finance experience and current insurance leadership.
Darryl D. Button appointed to the board on November 3, 2026
No committee assignments yet, per the filing
Button has been president and CEO of Pacific Mutual Holding Company since April 2022
Previously served as First American's chief financial officer from 2017 to 2021
First Western Financial furnished an investor presentation as Exhibit 99.1 to a Form 8-K filed November 3, 2026, for use with investors and analysts during fiscal 2026. The deck reports balance sheet figures as of September 30, 2026, including $3.42 billion in assets and $2.92 billion in deposits, but the filing contains no new earnings release or guidance, and the information is furnished under Regulation FD rather than filed.
Balance sheet as of 9/30/2026: assets $3.42 billion, total loans $2.81 billion, total deposits $2.92 billion, AUM $7.21 billion
Deck cites tangible book value per share of $26.28 at 9/30/2026 and a stock price of 1.18 times tangible book value as of October 30, 2026
Insiders own about 13.1% of shares outstanding, per the April 2026 proxy statement; average annual net charge-offs were 8 basis points over the last 10 years
Safehold disclosed an estimated $9,867 million of unrealized capital appreciation (UCA) in its owned residual portfolio as of September 30, 2026, calculated as Combined Property Value of $16,812 million less Ground Lease Cost of $6,945 million. The filing is a valuation disclosure that sets out the methodology and limitations, with no prior-period comparison, so it does not show a clear change in direction for shareholders.
Estimated UCA in the owned residual portfolio: $9,867 million as of September 30, 2026
Combined Property Value: $16,812 million; Ground Lease Cost: $6,945 million
Independent valuation firm CBRE, Inc. prepares the property value reports; the company intends to value each Ground Lease about every 12 months and no less often than every 24 months
CBRE states its reports do not specifically value Safehold's securities
Werner Enterprises said it will participate in two investment conferences in November 2026: the Baird 2026 Global Industrial Conference on November 10 and the 2026 Stephens Annual Investment Conference on November 17. The filing contains no financial results or guidance, so it gives shareholders no new performance information.
Baird 2026 Global Industrial Conference: investor meetings on Tuesday, November 10, 2026, in Chicago
2026 Stephens Annual Investment Conference: investor meetings on Tuesday, November 17, 2026, in Nashville
Management fireside chat at the Stephens conference from 2:45 p.m. to 3:20 p.m. CT, with a live webcast on werner.com
On October 31, 2026, Enhanced Group Inc. amended Transaction Support Agreements with its controlling shareholder Enhanced Holdings LP, CEO Maximilian Martin and Aron D'Souza. The amendments remove the six-month lock-up release for these holders, so their remaining locked-up Class A shares stay restricted until twelve months after the May 7, 2026 business combination closing. The filing also confirms a one-for-ten reverse stock split that took effect October 29, 2026.
Amendments dated October 31, 2026 cover Enhanced Holdings LP, Maximilian Martin (CEO) and Aron D'Souza.
The six-month lock-up release is eliminated for these supporting shareholders; remaining shares stay locked until twelve months after the May 7, 2026 closing.
Transaction Support Agreements with the company's other shareholders were not amended.
The one-for-ten reverse split of Class A and Class B common stock took effect October 29, 2026, and Class A shares continue to trade as ENHA on the NYSE.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.